Retinoblastoma-related protein pRb2/p130 and its binding to the B-myb promoter increase during human neuroblastoma differentiation

Journal of Cellular Biochemistry

Volumn 67, Issue 3, 1997, Pages 297-303

  Raschellà, Giuseppe ^a   Tanno, Barbara ^a   Bonetto, Francesco ^b   Amendola, Roberto ^a   Battista, Tullio ^b   De Luca, Antonio ^c   Giordano, Antonio ^c   Paggi, Marco G ^b  

^a ENEA   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

B myb; C myb; Differentiation; E2F; Neuroblastoma; P107; PRb; PRb2 p130; Promoter; Retinoblastoma family

Indexed keywords

RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

ARTICLE; CELL DIFFERENTIATION; DEPHOSPHORYLATION; ELECTROPHORETIC MOBILITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NEUROBLASTOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; TUMOR SUPPRESSOR GENE;

CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL NUCLEUS; CYTOPLASM; DNA, NEOPLASM; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F4 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEURITES; NEUROBLASTOMA; NEURONS; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROMOTER REGIONS (GENETICS); PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MYB; RETINOBLASTOMA PROTEIN; RETINOBLASTOMA-LIKE PROTEIN P107; RETINOBLASTOMA-LIKE PROTEIN P130; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0030670241     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19971201)67:3<297::AID-JCB2>3.0.CO;2-R     Document Type: Article

References (36)

1. Baldi A, De Luca A, Claudio PP, Baldi F, Giordano GG, Tommasino M, Paggi MG, Giordano A (1995): The Rb2/ p130 gene product is a nuclear protein whose phosphorylation is cell cycle regulated. J Cell Biochem 59:402-408.
2. Beijersbergen RL, Bernards R (1996): Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins. Biochim Biophys Acta Rev Cancer 1287:103-120.
3. Bennett JD, Farlie PG, Watson RJ (1996): E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts. Oncogene 13:1073-1082.
4. Bies J, Hoffman B, Amanullah A, Giese T, Wolff L (1996): B-Myb prevents growth arrest associated with terminal differentiation of monocytic cells. Oncogene 12:355-363.
5. Cobrinik D, Lee MH, Hannon G, Mulligan G, Bronson RT, Dyson N, Harlow E, Beach D, Weinberg RA, Jacks T (1996): Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev 10:1633-1644.
6. De Luca A, MacLachlan TK, Bagella L, Dean C, Howard CM, Claudio PP, Baldi A, Khalili K, Giordano A (1997): A unique domain of pRb2/p130 acts as an inhibitor of cdk2 kinase activity. J Biol Chem 292:20971-20974.
7. Helman LJ, Thiele CJ, Linehan WM, Nelkin BD, Baylin SB, Israel MA (1987): Molecular markers of neuroendocrine development and evidence of environmental regulation. Proc Natl Acad Sci USA 84:2336-2339.
8. Herwig S, Strauss M (1997): The retinoblastoma protein: A master regulator of cell cycle, differentiation and apoptosis. Eur J Biochem 246:581-601.
9. Hurford RK Jr, Cobrinik D, Lee MH, Dyson N (1997): pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev 11:1447-1463.
10. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA (1992): Effects of an Rb mutation in the mouse. Nature 359:295-300.
11. Kranenburg O, Scharnhorst V, van der Eb AJ, Zantema A (1995): Inhibition of cyclin-dependent kinase activity triggers neuronal differentiation of mouse neuroblastoma cells. J Cell Biol 131:227-234.
12. Lam EW, Watson RJ (1993): An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription. EMBO J 12:2705-2713.
13. Lam EW, Bennett JD, Watson RJ (1995): Cell-cycle regulation of human B-myb transcription. Gene 160:277-281.
14. Lee EY, Chang CY, Hu N, Wang YC, Lai CC, Herrup K, Lee WH, Bradley A (1992): Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis [see comments]. Nature 359:288-294.
15. Lindeman GJ, Gaubatz S, Livingston DM, Ginsberg D (1997): The subcellular localization of E2F-4 is cell-cycle dependent. Proc Natl Acad Sci USA 94:5095-5100.
16. Lotan R, Francis GE, Freeman CS, Waxman S (1990): Differentiation therapy. Cancer Res 50:3453-3464.
17. MacLachlan TK, Sang N, Giordano A (1995): Cyclins, cyclin-dependent kinases and Cdk inhibitors: Implications in cell cycle control and cancer. Eukariotic Gene Expr 5:127-156.
18. Moberg K, Starz MA, Lees JA (1996): E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol Cell Biol 16:1436-1449.
19. Moberg KH, Logan TJ, Tyndall WA, Hall DJ (1992): Three distinct elements within the murine c-myc promoter are required for transcription. Oncogene 7:411-421.
20. Mudryj M, Hiebert SW, Nevins JR (1990): A role for the adenovirus inducible E2F transcription factor in a proliferation dependent signal transduction pathway. EMBO J 9:2179-2184.
21. Negroni A, Scarpa S, Romeo A, Ferrari S, Modesti A, Raschellà G (1991): Decrease of proliferation rate and induction of differentiation by a MYCN antisense DNA oligomer in a human neuroblastoma cell line. Cell Growth Differ 2:511-518.
22. Paggi MG, Baldi A, Bonetto F, Giordano A (1996): Retinoblastoma protein family in cell cycle and cancer: A review. J Cell Biochem 62:418-430.
23. Pertile P, Baldi A, De Luca A, Bagella L, Virgilio L, Pisano MM, Giordano A (1995): Molecular cloning, expression, and developmental characterization of the murine retinoblastoma-related gene Rb2/p130. Cell Growth Differ 6:1659-1664.
24. Raschellà G, Negroni A, Skorski T, Pucci S, Nieborowska-Skorska M, Romeo A, Calabretta B (1992): Inhibition of proliferation by c-myb antisense RNA and oligodeoxynucleotides in transformed neuroectodermal cell lines. Cancer Res 52:4221-4226.
25. Raschellà G, Negroni A, Sala A, Pucci S, Romeo A, Calabretta B (1995): Requirement of B-myb function for survival and differentiative potential of human neuroblastoma cells. J Biol Chem 270:8540-8545.
26. Raschellà G, Negroni A, Pucci S, Amendola R, Valeri S, Calabretta B (1996): B-myb transcriptional regulation and mRNA stability during differentiation of neuroblastoma cells. Exp Cell Res 222:395-399.
27. Raschellà G, Tanno B, Bonetto F, Negroni A, Claudio PP, Baldi A, Amendola R, Calabretta B, Giordano A, Paggi MG (submitted): Retinoblastoma family genes induce differentiation in neuroblastoma cells and downregulate B-myb promoter.
28. Richon VM, Lyle RE, McGehee RE Jr. (1997): Regulation and expression of retinoblastoma proteins p107 and p130 during 3T3-L1 adipocyte differentiation. J Biol Chem 272:10117-10124.
29. Sala A, Casella I, Bellon T, Calabretta B, Watson RJ, Peschle C (1996): B-myb promotes S phase and is a downstream target of the negative regulator p107 in human cells. J Biol Chem 271:9363-9367.
30. Seeger RC, Danon YL, Rayner S, Hoover F (1982): Definition of a Thy-1 determinant on human neuroblastoma, glioma, sarcoma and teratoma cells with a monoclonal antibody. J Immunol 128:983-989.
31. Sidle A, Palaty C, Dirks P, Wiggan O, Kiess M, Gill RM, Wong AK, Hamel PA (1996): Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation. Crit Rev Biochem Mol Biol 31:237-271.
32. Thiele CJ, Reynolds CP, Israel MA (1985): Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature 313: 404-406.
33. Thiele CJ, Cohen PS, Israel MA (1988): Regulation of c-myb expression in human neuroblastoma cells during retinoic acid-induced differentiation. Mol Cell Biol 8:1677-1683.
34. Tsokos M, Scarpa S, Ross RA, Triche TJ (1996): Differentiation of human neuroblastoma recapitulates neural crest development - study of morphology, neurotransmitter enzymes, and extracellular-matrix proteins. Am J Pathol 128:484-496.
35. Weinberg RA (1995): The retinoblastoma protein and cell cycle control. Cell 81:323-330.
36. Zwicker J, Liu NS, Engeland K, Lucibello FC, Müller R (1996): Cell cycle regulation of E2F site occupation in vivo. Science 271:1595-1597.